NO20013651D0 - Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections - Google Patents

Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections

Info

Publication number
NO20013651D0
NO20013651D0 NO20013651A NO20013651A NO20013651D0 NO 20013651 D0 NO20013651 D0 NO 20013651D0 NO 20013651 A NO20013651 A NO 20013651A NO 20013651 A NO20013651 A NO 20013651A NO 20013651 D0 NO20013651 D0 NO 20013651D0
Authority
NO
Norway
Prior art keywords
prophylactic
infections
therapeutic treatment
inorganic compounds
phosphorus inorganic
Prior art date
Application number
NO20013651A
Other languages
Norwegian (no)
Other versions
NO20013651L (en
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of NO20013651D0 publication Critical patent/NO20013651D0/en
Publication of NO20013651L publication Critical patent/NO20013651L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20013651A 1999-01-26 2001-07-25 Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections NO20013651L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19902924A DE19902924A1 (en) 1999-01-26 1999-01-26 Use of organophosphorus compounds for the prophylactic and therapeutic treatment of infections
PCT/EP2000/000542 WO2000044358A2 (en) 1999-01-26 2000-01-25 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections

Publications (2)

Publication Number Publication Date
NO20013651D0 true NO20013651D0 (en) 2001-07-25
NO20013651L NO20013651L (en) 2001-09-18

Family

ID=7895365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013651A NO20013651L (en) 1999-01-26 2001-07-25 Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections

Country Status (14)

Country Link
EP (1) EP1146880A2 (en)
JP (1) JP2002535354A (en)
CN (1) CN1337881A (en)
AU (1) AU2439900A (en)
CA (1) CA2360661A1 (en)
CZ (1) CZ20012584A3 (en)
DE (1) DE19902924A1 (en)
HU (1) HUP0105310A3 (en)
IL (1) IL144115A0 (en)
NO (1) NO20013651L (en)
PL (1) PL349910A1 (en)
SK (1) SK10552001A3 (en)
TR (1) TR200102151T2 (en)
WO (1) WO2000044358A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842719B2 (en) 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004085448A2 (en) * 2003-03-19 2004-10-07 Genzyme Corporation Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
WO2010108190A1 (en) * 2009-03-20 2010-09-23 University Of Iowa Research Foundation Prenylated bisphosphonates as anti-tuberculosis agents
CN104026151A (en) * 2014-06-19 2014-09-10 南京麦思德餐饮管理有限公司 Alfalfa seed soaking agent
EP3338783B1 (en) 2014-09-12 2024-01-24 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
CN105403221B (en) * 2015-10-27 2018-01-23 广东欧珀移动通信有限公司 The generation method and mobile terminal of a kind of navigation way
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170944A (en) * 1962-11-20 1965-02-23 Stauffer Chemical Co Haloacetonyl phosphonates and a method of preparing them
US3372209A (en) * 1964-08-24 1968-03-05 Monsanto Co Diphosphorus ester hydrocarbon diols
BE687874A (en) * 1965-10-06 1967-04-06
US3532774A (en) * 1966-09-29 1970-10-06 Monsanto Co Phosphinites,phosphine oxides and process for preparing
JPS4861259A (en) * 1971-12-02 1973-08-28
US4254114A (en) * 1979-01-02 1981-03-03 The Proctor & Gamble Company Control of pyrophosphate microorganisms with organophosphonates
JPS5655394A (en) * 1979-10-12 1981-05-15 Otsuka Chem Co Ltd 1,2-di alkoxycarbonylmethylamino ethylene-1,2-disulfonic acid phenyl ester derivative, its preparation, and herbicide containing said compound
DE3208600A1 (en) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf AMIDINODIPHOSPHONIC ACIDS
CH664158A5 (en) * 1984-07-18 1988-02-15 Symphar Sa DERIVATIVES PROPYLIDENEDIPHOSPHONATES-1,3 SUBSTITUTED IN POSITION 2, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US4820698A (en) * 1985-11-04 1989-04-11 The Procter & Gamble Company Antimicrobial agents and process for their manufacture
US5196409A (en) * 1989-08-20 1993-03-23 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
DE4336099A1 (en) * 1993-10-22 1995-04-27 Boehringer Mannheim Gmbh New 2,4-diphosphonoglutaric acid derivatives, processes for their preparation and medicaments containing these compounds
AU4285896A (en) * 1994-11-18 1996-06-19 Amira, Inc. Phosphinic creatine compounds having antiviral activity
DE19532235A1 (en) * 1995-08-31 1997-03-06 Keppler Bernhard K Priv Doz Dr New antibacterial contg. osteotropic mol. fragments
GB9613637D0 (en) * 1996-06-28 1996-08-28 Agrevo Uk Ltd Fungicidal compositions
EP0944635A4 (en) * 1996-10-09 2000-07-05 Elizanor Biopharmaceuticals In Diphosphonate therapeutic compounds

Also Published As

Publication number Publication date
AU2439900A (en) 2000-08-18
CA2360661A1 (en) 2000-08-03
CN1337881A (en) 2002-02-27
EP1146880A2 (en) 2001-10-24
IL144115A0 (en) 2002-05-23
WO2000044358A2 (en) 2000-08-03
HUP0105310A2 (en) 2002-06-29
JP2002535354A (en) 2002-10-22
DE19902924A1 (en) 2000-08-03
NO20013651L (en) 2001-09-18
WO2000044358A3 (en) 2001-03-15
PL349910A1 (en) 2002-10-07
TR200102151T2 (en) 2002-05-21
CZ20012584A3 (en) 2002-01-16
HUP0105310A3 (en) 2002-08-28
SK10552001A3 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
NO20013380L (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
ATE251903T1 (en) USE OF ORGANIC PHOSPHOROGANIC COMPOUNDS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF INFECTIONS
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20014314L (en) Compositions and methods for the treatment of staphylococcal infection
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20042208L (en) Vaginally administered anti-dysrhythmic agents for the treatment of pelvic pain
NO20005885L (en) Combination therapy for the treatment of refractory depression
NO20023482D0 (en) Procedure for the treatment of substance abuse
NO20015772L (en) Compounds and methods for the treatment of post-traumatic stress syndrome
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2798900A (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
NO20013651D0 (en) Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections
NO20015738D0 (en) Therapeutic use of melatonin
NO20020784L (en) Medication for the treatment of fractures
NO20043445L (en) Combination therapy for the treatment of bacterial infections
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20002481D0 (en) Combination therapy for the treatment of AIDS
NO20012540D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20022990D0 (en) Method and composition for the treatment of pain
NO20013464D0 (en) Use of 3-isoxazolidinones and hydroxylamino acids for the treatment of infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application